Pharma exports to decline in next 5 years: Crisil
18/05/2016 10:12
A report has said that the pharmaceutical sector is heading for a tough time as exports growth in formulations in US dollar terms is expected to almost halve to 10-12 per cent annually over the next five years.
Commenting on the issue, a Crisil Official said, "Exports growth in formulations (in US dollar terms) is expected to decline sharply to 10-12 per cent annually over the next 5 years, compared with a growth of 19 per cent seen in the last decade."
“Exports of generics have been the growth engine of the industry for a long while now, but the script is changing because the value of drugs going off-patent is declining even as pricing pressures are increasing,” he added.
As per reports, the annual sales growth of generic drugs in the US, the largest generics market, is seen slowing to 8-9 per cent over the next five years, and decelerate even more after that.
As per reports, Indian companies have increased their R&D spend for the top 30, it has shot up to 6.5 per cent of revenue in fiscal 2015 from 3.8 per cent a decade back.
18/05/2016 10:12
Commenting on the issue, a Crisil Official said, "Exports growth in formulations (in US dollar terms) is expected to decline sharply to 10-12 per cent annually over the next 5 years, compared with a growth of 19 per cent seen in the last decade."
“Exports of generics have been the growth engine of the industry for a long while now, but the script is changing because the value of drugs going off-patent is declining even as pricing pressures are increasing,” he added.
As per reports, the annual sales growth of generic drugs in the US, the largest generics market, is seen slowing to 8-9 per cent over the next five years, and decelerate even more after that.
As per reports, Indian companies have increased their R&D spend for the top 30, it has shot up to 6.5 per cent of revenue in fiscal 2015 from 3.8 per cent a decade back.
